Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Sundry Debtors

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹1,538 Cr₹848 Cr₹576 Cr₹388 Cr₹331 Cr

What is the latest Sundry Debtors ratio of MANKIND PHARMA ?

The latest Sundry Debtors ratio of MANKIND PHARMA is ₹1,538 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹1,538 Cr
Mar2024₹848 Cr
Mar2023₹576 Cr
Mar2022₹388 Cr
Mar2021₹331 Cr

How is Sundry Debtors of MANKIND PHARMA Trending?

Years Sundry Debtors % Change
Mar2025 ₹1,538 Cr
81.35
Mar2024 ₹848 Cr
47.16
Mar2023 ₹576 Cr
48.50
Mar2022 ₹388 Cr
17.41
Mar2021 ₹331 Cr -

Compare Sundry Debtors of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹93,703.5 Cr 1.6% 14.2% -11% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,332.0 Cr 4.7% -0.3% -3.1% Stock Analytics
DIVIS LABORATORIES ₹170,800.0 Cr 2.3% 6.8% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,578.0 Cr 2.5% -1.7% 26.5% Stock Analytics
DR REDDYS LABORATORIES ₹113,075.0 Cr 11.3% 7.6% 12.5% Stock Analytics
CIPLA ₹105,662.0 Cr 5.9% 7.3% -14.1% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.6%

14.2%

-11%

SENSEX

-3%

5.8%

-3.4%


You may also like the below Video Courses